SEOVF - Sernova to Provide Two Program Updates in Podium Presentations at 2023 IPITA Congress | Benzinga
Dr. Piotr Witkowski presenting new data from ongoing Phase 1/2 clinical trial of the Cell Pouch System™ in patients with type 1 diabetes (T1D)
Dr. Alice Tomei presenting preclinical data on transplantation of conformal coated islet cells in pre-vascularized Cell Pouch
LONDON, Ontario and WINDHAM COUNTY, Conn., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, today announced two oral presentations at the upcoming International Pancreas and Islet Transplant Association (IPITA), International Xenotransplantation Association (IXA) Cell Transplant & Regenerative Medicine Association (CTRMA) joint congress taking October 26-29, 2023 in San Diego, CA.
More details about the conference, including accepted abstracts, are available on the IPITA website HERE. In alignment with the embargo policy, Sernova plans to share details from both speakers lectures following completion of their presentations.
Presentation details:
Abstract #: 105.1
Title: Islet allotransplantation into pre-vascularized Sernova Cell Pouch™ - Lessons learned from the first patient cohort
Presenter: Piotr Witkowski, United States, Associate Professor of Surgery, University of Chicago
Session: Islet Transplantation: Engineering the Islet Site
Session Date and Time: Thursday, October 26, 2023 from 2:45 p.m. to 3:45 p.m. PT
Abstract #: 205.1
Title: Transplantation of conformal coated islets in a pre-vascularized Cell Pouch™ device for beta cell replacement in diabetic rats
Presenter: Alice Tomei, United States, Associate Professor - Biomedical Engineering and Diabetes Research Institute, University of Miami
Session: Engineering the site (Joint)
Session Date and Time: Friday, October 27, 2023 from 8:30 a.m. to 9:30 a.m. PT
ABOUT SERNOVA CORP. AND THE CELL POUCH SYSTEM PLATFORM FOR CELL THERAPY
Sernova Corp. is a clinical-stage biotechnology company that is developing therapeutic cell technologies ...